Predictive Technology Group, Inc. (PRED)

OTCMKTS: PRED · Delayed Price · USD
0.0076
0.0000 (0.00%)
Jan 27, 2022 3:11 PM - Market closed

Company Description

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps).

It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditions; and regenerative medicine products, including AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte for use in regenerative medicine applications.

It has a collaboration agreement with Atrin Pharmaceuticals LLC to develop molecular diagnostic tools to facilitate enhanced selection of cancer patients.

The company was formerly known as Global Enterprises Group, Inc. and changed its name to Predictive Technology Group, Inc. in July 2015. Predictive Technology Group, Inc. was founded in 2005 and is headquartered in Salt Lake City, Utah.

Predictive Technology Group, Inc.
Predictive Technology Group Logo
CountryUnited States
Founded2005
IndustryBiotechnology
SectorHealth Care
Employees62

Contact Details

Address:
2735 Parleys Way
Salt Lake City, UT 84109
United States
Phone801 584 3600

Stock Details

Ticker SymbolPRED
ExchangeOTCMKTS
Fiscal YearFebruary - January
Reporting CurrencyUS Dollars
CIK Code1382943

Key Executives

NamePosition
Bradley C. RobinsonChief Executive Officer, President and Director
Paul S. EvansChief Operating Officer
Simon Brewer CPAConsultant
Dr. Bruce D. Forrest B.S., M.B.A., M.D.Chief Development Officer

Latest SEC Filings

DateTypeTitle
Jan 24, 20228-KCurrent report
Jan 6, 20228-KCurrent report
Oct 7, 20218-KCurrent report
Sep 28, 2021NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Aug 11, 20218-KCurrent report
Jun 21, 20218-KCurrent report
May 17, 202110-QQuarterly report [Sections 13 or 15(d)]
Apr 13, 20214Statement of changes in beneficial ownership of securities
Apr 13, 20214Statement of changes in beneficial ownership of securities
Apr 13, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings